Research programme: hormone therapies - Viramal

Drug Profile

Research programme: hormone therapies - Viramal

Alternative Names: Progestin-only contraceptive; Vaginal Danazol; VML 0501

Latest Information Update: 03 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Viramal
  • Class Hormonal contraceptives; Hormones; Oxazoles; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Estrogen receptor antagonists; Progesterone receptor agonists; Progesterone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Endometriosis; Menopausal syndrome; Pregnancy

Most Recent Events

  • 28 Nov 2017 Viramal plans a phase II trial of vaginal danazol versus oral danazol for Endometriosis in November 2017 (NCT03352076)
  • 24 May 2016 Preclinical trials in Endometriosis in United Kingdom (Vaginal) before May 2016
  • 24 May 2016 Preclinical trials in Menopausal syndrome in United Kingdom (Transdermal, Topical) before May 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top